The primary purpose of the study is to evaluate the change from baseline after 4 weeks of topical administration of TV-45070 (4% and 8% ointment) compared with placebo for the relief of symptoms of primary OA affecting a single knee

Read more: http://www.clinicaltrials.gov/ct2/show/NCT02068599?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30